Racial Differences in Secondary Treatment Pathways and Survival in Localized Prostate Cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Disparities in Secondary Treatment Approaches and Survival Rates for Localized Prostate Cancer Among Racial Groups

  • By

  • Jessica Acolin

  • Yibai Zhao

  • Sarah K. Holt

  • John L. Gore

  • Ting Martin Ma

  • Ruth Etzioni

  • Yaw A. Nyame

  • July 21, 2026

Share

  • 1

    Black men are 1.6 times more likely to be diagnosed with prostate cancer and over 2 times more likely to die from it compared to White men.

  • 2

    Disparities in prostate cancer outcomes are driven by structural, social, health, and individual factors, including discriminatory policies and health literacy.

  • 3

    Black patients receive fewer definitive treatments and experience delays in treatment compared to White patients, contributing to racial disparities in outcomes.

  • 4

    The study assessed racial differences in secondary treatment receipt and mortality among patients with localized prostate cancer using Medicare claims data.

  • 5

    Under equitable treatment conditions, Black and White patients have similar outcomes, but disparities in secondary treatment may contribute to mortality differences.

Original Source(s)

Related Content